And hypomethylation of Piezo2 mediated a longer life span for breast cancer, bladder cancer, and kidney cancer patients and a shorter life span for brain cancer, stomach cancer, uveal cancer, and lung cancer patients. This evidence concerns the gene PIEZO2 and breast carcinoma.